The Senate Appropriations Committee approves a $3.9 billion budget for the agency in fiscal 2013, including $319 million in federal funding for device activities.
Senate appropriators plan to increase their oversight of FDA’s information technology investments as the agency works to address problems cited in a recent Government Accountability Office report.
The Senate Appropriations Committee explains its interest in FDA’s IT systems in a report accompanying the fiscal 2013 Agriculture/FDA appropriations...
A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.
An upcoming US FDA advisory panel meeting will discuss adding a new indication to allow dermal fillers to be used in the upper chest, or décolletage. Plastic surgeons expect this could drive interest in the procedure, which is already performed off-label.
A system of pre-regulatory review consultations for innovative drugs and devices in South Korea has contributed to the accelerated development of such products.
